Targeting melanocortin receptors as potential novel therapeutics

Pharmacology and Therapeutics

Volumn 111, Issue 1, 2006, Pages 1-15

  Getting, Stephen J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cardiovascular; Cytokine; Infection; Inflammation; Leukocyte; Melanocortin

Indexed keywords

ADENYLATE CYCLASE; ALPHA INTERMEDIN; CORTICOTROPIN; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERMEDIN; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROOPIOMELANOCORTIN;

ANTIPYRETIC ACTIVITY; CARDIOVASCULAR EFFECT; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; IMMUNOCOMPETENT CELL; INFECTION; INFECTION CONTROL; INFLAMMATION; LEUKOCYTE MIGRATION; MELANOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SEXUAL HEALTH; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS, GOUTY; ASTHMA; CARDIOVASCULAR DISEASES; DRUG DESIGN; FEVER; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; OBESITY; PRO-OPIOMELANOCORTIN; RECEPTORS, MELANOCORTIN; SIGNAL TRANSDUCTION;

EID: 33646814991     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.06.022     Document Type: Review

References (162)

1. Abdel-Malek Z.A. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 58 (2001) 434-441
2. Abou-Mohamed G., Papapetropoulos A., Ulrich D., Catravas J.D., Tuttle R.R., and Caldwell R.W. HP-228, a novel synthetic peptide inhibits the induction of nitric oxide synthase in vivo but not in vitro. J Pharm Exp Ther 275 (1995) 584-591
3. Adachi S., Nakano T., Vliagoftis H., and Metcalfe D.D. Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. J Immunol 163 (1999) 3363-3368
4. Adan R.A., Hillebrand J.J., De Rijke C., Nijenhuis W., Vink T., Garner K.M., et al. Melanocortin system and eating disorders. Ann N Y Acad Sci 994 (2003) 267-274
5. Airaghi L., Capra R., Pravettoni G., Maggiolo F., Suter F., Lipton J.M., et al. Elevated concentrations of plasma alpha-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients. J Lab Clin Med 133 (1999) 309-315
6. Al-Obeidi F., Castrucci A.M., Hadley M.E., and Hruby V.J. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J Med Chem 32 (1989) 2555-2561
7. Altavilla D., Cainazzo M.M., Squadrito F., Guarini S., Bertolini A., and Bazzani C. Tumour necrosis factor-α as a target of melanocortins in haemorrhagic shock in the anaesthetized rat. Br J Pharmacol 124 (1998) 1587-1590
8. Alvaro J.D., Tatro J.B., Quillan J.M., Fogliano M., Elsenhard M., Lerner M.R., et al. Morphine down regulates melanocortin 4 receptor expression in brain regions that mediate opiate addiction. Mol Pharmacol 50 (1996) 583-591
9. Argiolas A., Melis M.R., Murgia S., and Schioth H.B. ACTH- and alpha-MSH-induced grooming, stretching, yawning and penile erection in male rats: site of action in the brain and role of melanocortin receptors. Brain Res Bull 51 (2000) 425-431
10. Barcellini W., Colombo G., La Maestra L., Clerici G., Garofalo L., Brini A.T., et al. Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes. J Leukoc Biol 68 (2000) 693-699
11. Bar-Ilan A., Savion N., Naveh N., and Ilan A.B. Alpha melanocyte stimulating hormone (alpha-MSH) enhances eicosanoid production by bovine retinal pigment epithelium. Prostaglandins 43 (1992) 31-44
12. Baxter G.F. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol 97 (2002) 268-275
13. Bazzani C., Guarini S., Botticelli A.R., Zaffe D., Tomasi A., Bini A., et al. Protective effect of melanocortin peptides in rat myocardial ischemia. J Pharmacol Exp Ther 297 (2001) 1082-1087
14. Bazzani C., Mioni C., Ferrazza G., Cainazzo M.M., Bertolini A., and Guarini S. Involvement of the central nervous system in the protective effect of melanocortins in myocardial ischaemia/reperfusion injury. Resuscitation 52 (2002) 109-115
15. Beckwith B.E., Tinius T.P., Hruby V.J., al-Obeidi F., Sawyer T.K., and Affholter J.A. The effects of structure-conformation modifications of melanotropin analogs on learning and memory: D-amino acid substituted linear and cyclic analogs. Peptides 10 (1989) 361-368
16. Ben-Chetrit E., and Levy M. Colchicine: 1998 update. Semin Arthritis Rheum 28 (1998) 48-59
17. Benjannet S., Rondeau N., Day R., Chretien M., and Seidah N.G. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA 88 (1991) 3564-3568
18. Bertolini A., and Gessa G.L. Behavioral effects of ACTH and MSH peptides. J Endocrinol Invest 4 (1981) 241-251
19. Bertolini A., Guarini S., Rompianesi E., and Ferrari W. Alpha-MSH and other ACTH fragments improve cardiovascular function and survival in experimental hemorrhagic shock. Eur J Pharmacol 130 (1986) 19-26
20. Bhardwaj R., Becher E., Mahnke K., Hartmeyer M., Schwarz T., Scholzen T., et al. Evidence for the differential expression of the functional alpha-melanocyte-stimulating hormone receptor MC-1 on human monocytes. J Immunol 158 (1997) 3378-3384
21. Bloomfield G.A., Scott A.P., Lowry P.J., Gikes J.J.H., and Rees L.H. A reappraisal of human b-MSH. Nature 252 (1974) 492-493
22. Bohm M., and Luger T.A. The role of melanocortins in skin homeostasis. Horm Res 54 (2000) 287-293
23. Bohm M., Schulte U., Kalden H., and Luger T.A. Alpha-melanocyte-stimulating hormone modulates activation of NF-kappa B and AP-1 and secretion of interleukin-8 in human dermal fibroblasts. Ann N Y Acad Sci 885 (1999) 277-286
24. Boston B.A., and Cone R.D. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 137 5 (1996) 2043-2050
25. Bousquet J., Chanez P., Lacoste J.Y., Barneon G., Ghavanian N., Enander I., et al. Eosinophilic inflammation in asthma. N Engl J Med 323 (1990) 1033-1039
26. Bravenboer B., Kappelle A.C., van Buren T., Erkelens D.W., and Gispen W.H. ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats. Acta Diabetol 30 (1993) 21-24
27. Buggy J.J. Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. Biochem J 331 Pt 1 (1998) 211-216
28. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J., et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141 (2000) 3518-3521
29. Cannon J.G., Tatro J.B., Reichlin S., and Dinarello C.A. Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. J Immunol 137 (1986) 2232-2236
30. Castro M.G., and Morrison E. Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crictical Reviews in Neurobiology 11 1 (1997) 35-57
31. Catania A., Gerloni V., Procaccia S., Airaghi L., Manfredi M.G., Lomater C., et al. The anticytokine neuropeptide alpha-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. Neuroimmunomodulation 1 (1994) 321-328
32. Catania A., Manfredi M.G., Airaghi L., Vivirito M.C., Capetti A., and Milazzo F. Plasma concentration of cytokine antagonists in patients with HIV infection. Neuroimmunomodulation 1 (1994) 42-49
33. Catania A., Rajora N., Capsooni F., Minonzio F., Star R.A., and Lipton J.M. The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 17 4 (1996) 675-679
34. Catania A., Airaghi L., Garofalo L., Cutuli M., and Lipton J.M. The neuropeptide α-MSH in HIV infection and other disorders in humans. Ann N Y Acad Sci (1998) 848-856
35. Catania A., Garofalo L., Cutuli M., Gringeri A., Santagostino E., and Lipton J.M. Melanocortin peptides inhibit production of proinflammatory cytokines in blood of HIV-infected patients. Peptides 19 (1998) 1099-1104
36. Catania A., Gatti S., Colombo G., and Lipton J.M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 56 (2004) 1-29
37. Ceriani G., Diaz J., Murphree S., Catania A., and Lipton J.M. The neuropeptide alpha-melanocyte stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1 (1994) 28-32
38. Chhajlani V. Distribution of cDNA for melanocortin receptor subtypes in human tissues. Biochem Mol Biol Int 38 (1996) 73-80
39. Chhajlani V., and Wikberg J.E.S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS 309 3 (1992) 417-420
40. Chiao H., Kohda Y., McLeroy P., Craig L., Housini I., and Star R.A. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99 (1997) 1165-1172
41. Colombo G., Buffa R., Bardella M.T., Garofalo L., Carlin A., Lipton J.M., et al. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 10 (2002) 208-216
42. Cutuli M., Cristiani S., Lipton J.M., and Catania A. Antimicrobial effects of α-MSH peptides. J Leukoc Biol 67 (2000) 233-239
43. Davidson J., Milton A.S., and Rotondo D. Alpha-melanocyte-stimulating hormone suppresses fever and increases in plasma levels of prostaglandin E2 in the rabbit. J Physiol 451 (1992) 491-502
44. De Monchy J.G., Kauffman H.F., Venge P., Koeter G.H., Jansen H.M., Sluiter H.J., et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 131 (1985) 373-376
45. de Wied D. Behavioural pharmacology of neuropeptides related to melanocortins and the neurohypophyseal hormones. Eur J Pharmacol 375 (1999) 1-11
46. Delgado Hernandez R., Demitri M.T., Carlin A., Meazza C., Villa P., Ghezzi P., et al. Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte-stimulating hormone. Neuroimmunomodulation 6 (1999) 187-192
47. Delgrado R., Carlin A., Airaghi L., Demitri M.T., Meda L., Galimberti D., et al. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol 63 (1998) 740-745
48. Desarnaud F., Labbe O., Eggerickx D., Vassart G., and Parmentier M. Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene. Biochem J 299 (1994) 367-373
49. Dewald O., Frangogiannis N.G., Zoerlein M., Duerr G.D., Klemm C., Knuefermann P., et al. Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species. Proc Natl Acad Sci USA 100 (2003) 2700-2705
50. Dieppe P.A., Crocker P.R., Corke C.F., Doyle D.V., Huskisson E.C., and Willoughby D.A. Synovial fluid crystals. Q J Med 48 (1979) 533-553
51. Drazen J.M., Israel E., and O'Byrne P.M. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340 (1999) 197-206
52. Drouin J., and Goodman H.M. Most of the coding region of rat ACTH beta-LPH precursor gene lacks intervening sequences. Nature 288 (1980) 610-613
53. Ellacott K.L., and Cone R.D. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog Horm Res 59 (2004) 395-408
54. Englaro W., Rezzonico R., Durand-Clement M., Lallemand D., Ortonne J.P., and Ballotti R. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem 270 (1995) 24315-24320
55. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., and Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 (1997) 165-168
56. Ferreira S.H., Lorenzetti B.B., Bristow A.F., and Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334 (1988) 698-700
57. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 53 (2002) 31-47
58. Gantz I., and Fong T.M. The melanocortin system. Am J Physiol Endocrinol Metab 284 (2003) E468-E474
59. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 268 11 (1993) 8246-8250
60. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268 20 (1993) 15174-15179
61. Gantz I., Shimoto Y., Konda Y., Miwa H., Dickinsn C.J., and Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun 200 3 (1994) 1214-1220
62. Gatti S., Colombo G., Buffa R., Turcatti F., Garofalo L., Carboni N., et al. Alpha-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation 74 (2002) 1678-1684
63. Gecse A., Ottlecz A., Farago M., Forster T., and Telegdy G. Effect of ACTH on prostaglandin induced vascular permeability. Acta Physiologica Academiae Scientiarum Hungaricae 55 4 (1980) 305-311
64. Gerritsen van der Hoop R., de Koning P., Boven E., Neijt J.P., Jennekens F.G., and Gispen W.H. Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats. Eur J Cancer Clin Oncol 24 (1988) 637-642
65. Gerritsen van der Hoop R., Hamers F.P., Neijt J.P., Veldman H., Gispen W.H., and Jennekens F.G. Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence. J Neurol Sci 126 (1994) 109-115
66. Getting S.J. Melanocortin peptides and their receptors: new targets for anti- inflammatory therapy. Trends Pharmacol Sci 23 (2002) 447
67. Getting S.J., Gibbs L., Clark A.J.L., Flower R.J., and Perretti M. POMC gene derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release and inhibit neutrophil migration in acute experimental inflammation. J Immunol 162 (1999) 7446-7453
68. Getting S.J., Allcock G.H., Flower R., and Perretti M. Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J Leukoc Biol 69 (2001) 98-104
69. Getting S.J., Christian H.C., Flower R.J., and Perretti M. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 46 (2002) 2765-2775
70. Getting S.J., Mahoney D.J., Cao T., Rugg M.S., Fries E., and Milner C.M. The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-alpha -inhibitor-independent manner. J Biol Chem 277 (2002) 51068-51076
71. Getting S.J., Christian H.C., Lam C.W., Gavins F.N., Flower R.J., Schioth H.B., et al. Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J Immunol 170 (2003) 3323-3330
72. Getting S.J., Di Filippo C., Christian H.C., Lam C.W., Rossi F., D'Amico M., et al. MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct. J Leukoc Biol 76 4 (2004) 845-853
73. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 (2002) S81-S96 (Suppl.)
74. Glyn J.R., and Lipton J.M. Hypothermic and antipyretic effects of centrally administered ACTH (1-24) and alpha-melanotropin. Peptides 2 (1981) 177-187
75. Grabbe S., Bhardwaj R.S., Mahnke K., Simon M.M., Schwarz T., and Luger T.A. Alpha-melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol 156 (1996) 473-478
76. Grieco P., Balse P.M., Weinberg D., MacNeil T., and Hruby V.J. D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity. J Med Chem 43 (2000) 4998-5002
77. Grieco P., Han G., Weinberg D., Van der Ploeg L.H., and Hruby V.J. Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6. Biochem Biophys Res Commun 292 (2002) 1075-1080
78. Guarini S., Bazzani C., Cainazzo M.M., Mioni C., Ferrazza G., Vergoni A.V., et al. Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides. J Pharmacol Exp Ther 291 (1999) 1023-1027
79. Guarini S., Schioth H.B., Mioni C., Cainazzo M., Ferrazza G., Giuliani D., et al. MC(3) receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias. Naunyn Schmiedebergs Arch Pharmacol 366 (2002) 177-182
80. Gura T. Having it all. Science 299 (2003) 850
81. Gutman A.B., and Yu T.F. Effects of adrenocorticotropic hormone(ACTH) in gout. Am J Med (1950) 24-30
82. Hamers F.P., Pette C., Neijt J.P., and Gispen W.H. The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats. Eur J Pharmacol 233 (1993) 177-178
83. Hannon R., Croxtall J.D., Getting S.J., Roviezzo F., Yona S., Paul-Clark M.J., et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J 17 (2003) 253-255
84. Hartmeyer M., Scholzen T., Becher E., Bhardwaj R.S., Schwarz T., and Luger T.A. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. J Immunol 159 (1997) 1930-1937
85. Hassoun H.T., Zou L., Moore F.A., Kozar R.A., Weisbrodt N.W., and Kone B.C. Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 282 (2002) G1059-G1068
86. Heinig J.A., Keeley F.W., Robson P., Sower S.A., and Youson J.H. The appearance of proopiomelanocortin early in vertebrate evolution: cloning and sequencing of POMC from a Lamprey pituitary cDNA library. Gen Comp Endocrinol 99 (1995) 137-144
87. Hench P. Effects of cortisone in the rheumatic diseases. Lancet 2 (1950) 483-484
88. Hench P.S., Slocumb C.H., Polley H.F., and Kendal E.C. Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases. J Am Med Assoc 144 (1950) 1327-1335
89. Herpin T.F., Yu G., Carlson K.E., Morton G.C., Wu X., Kang L., et al. Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties. J Med Chem 46 (2003) 1123-1126
90. Hiltz M.E., and Lipton J.M. Alpha-MSH peptides inhibit acute inflammation and contact sensitivity. Peptides 11 (1990) 979-982
91. 4, PAF and IL-8. Cytokine 4 (1992) 320-328
92. Holder J.R., and Haskell-Luevano C. Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies. Med Res Rev 24 (2004) 325-356
93. Hori T., Nakashima T., Take S., Kaizuka Y., Mori T., and Katafuchi T. Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 27 (1991) 309-313
94. Hruby V.J., Lu D., Sharma S.D., Castrucci A.L., Kesterson R.A., Al-Obeidi F.A., et al. Cyclic lactam α-melanotropin analogues of NDP-a-MSH with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem 38 (1995) 3454-3461
95. Huang Q.H., Entwistle M.L., Alvaro J.D., Duman R.S., Hruby V.J., and Tatro J.B. Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced fever. J Neurosci 17 (1997) 3343-3351
96. Ichiyama T., Campbell I.L., Furukawa S., Catania A., and Lipton J.M. Autocrine alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human glioma. J Neurosci Res 58 (1999) 684-689
97. Ichiyama T., Sakai T., Catania A., Barsh G.S., Furukawa S., and Lipton J.M. Inhibition of peripheral NF-kappaB activation by central action of alpha-melanocyte-stimulating hormone. J Neuroimmunol 99 (1999) 211-217
98. Ichiyama T., Okada K., Campbell I.L., Furukawa S., and Lipton J.M. NF-kappaB activation is inhibited in human pulmonary epithelial cells transfected with alpha-melanocyte-stimulating hormone vector. Peptides 21 (2000) 1473-1477
99. Jones S.P., Girod W.G., Palazzo A.J., Granger D.N., Grisham M.B., Jourd'Heuil D., et al. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol 276 (1999) H1567-H1573
100. Jones S.P., Trocha S.D., Strange M.B., Granger D.N., Kevil C.G., Bullard D.C., et al. Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 279 (2000) H2196-H2201
101. Kalden D.H., Scholzen T., Brzoska T., and Luger T.A. Mechanisms of the antiinflammatory effects of alpha-MSH. Role of transcription factor NF-kappa B and adhesion molecule expression. Ann N Y Acad Sci 885 (1999) 254-261
102. Kapas S., Purbrick A., and Hinson J.P. Role of tyrosine kinase and protein kinase C in the steroidogenic actions of angiotensin II, alpha-melanocyte-stimulating hormone and corticotropin in the rat adrenal cortex. Biochem J 305 Pt 2 (1995) 433-438
103. Kask A., Rago L., Mutulis F., Pahkla R., Wikberg J.E., and Schioth H.B. Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats. Biochem Biophys Res Commun 245 (1998) 90-93
104. Kedzierska K., Crowe S.M., Turville S., and Cunningham A.L. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev Med Virol 13 (2003) 39-56
105. Kis A., Yellon D.M., and Baxter G.F. Role of nuclear factor-kappaB activation in acute ischaemia-reperfusion injury in myocardium. Br J Pharmacol 138 (2003) 894-900
106. Klusa V., Svirskis S., Opmane B., Muceniece R., Skujins A., Mutulis F., et al. Evaluation of behavioural effects of neural melanocortin receptor antagonists injected ICV and in VTA in rats. Neuropeptides 32 (1998) 573-580
107. Konda Y., Gantz I., DelValle J., Shimoto Y., Miwa H., and Yamada T. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J Biol Chem 269 (1994) 13162-13166
108. La M., Cao T.V., Cerchiaro G., Chilton K., Hirabayashi J., Kasai K., et al. A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. Am J Pathol 163 (2003) 1505-1515
109. Labbe O., Desarnaud F., Eggerickx D., Vassart G., and Parmentier M. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 33 (1994) 4543-4549
110. Lam C.W., Getting S.J., and Perretti M. In vitro and in vivo induction of heme oxygenase 1 in mouse macrophages following melanocortin receptor activation. J Immunol 174 (2005) 2297-2304
111. Lefer A.M., Campbell B., Scalia R., and Lefer D.J. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. Circulation 98 (1998) 1322-1328
112. Liakos P., Chambaz E.M., Feige J.J., and Defaye G. Expression of ACTH receptors (MC2-R and MC5-R) in the glomerulosa and the fasciculata-reticularis zones of bovine adrenal cortex. Endocr Res 24 (1998) 427-432
113. Lipton J.M., and Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today 18 (1997) 140-145
114. Lipton J.M., Ceriani G., Macaluso A., McCoy D., Carnes K., Biltz J., et al. Antiinflammatory effects of the neuropeptide alpha-MSH in acute, chronic, and systemic inflammation. Ann N Y Acad Sci 741 (1994) 137-148
115. Luger T.A., Scholzen T., and Grabbe S. The role of alpha-melanocyte-stimulating hormone in cutaneous biology. J Investig Dermatol Symp Proc 2 (1997) 87-93
116. Luger T.A., Brzoska T., Scholzen T.E., Kalden D.H., Sunderkotter C., Armstrong C., et al. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann N Y Acad Sci 917 (2000) 232-238
117. Mandrika I., Muceniece R., and Wikberg J.E. Effects of melanocortin peptides on lipopolysaccharide/interferon-gamma- induced NF-kappaB DNA binding and nitric oxide production in macrophage- like RAW 264.7 cells: evidence for dual mechanisms of action. Biochem Pharmacol 61 (2001) 613-621
118. Manna S.K., and Aggarwal B.B. α-Melanocyte stimulating hormone inhibits the nuclear transcription factor NF-kB activation by various inflammatory agents. J Immunol 161 (1998) 2873-2880
119. Martin W.J., and MacIntyre D.E. Melanocortin receptors and erectile function. Eur Urol 45 (2004) 706-713
120. McClean C., and Lowry P.J. Natural occurrence but lack of melanotropic activity of g-MSH in fish. Nature 290 (1981) 341-343
121. McKenna K.E. Some proposals regarding the organization of the central nervous system control of penile erection. Neurosci Biobehav Rev 24 (2000) 535-540
122. Mioni C., Giuliani D., Cainazzo M.M., Leone S., Iannone C., Bazzani C., et al. Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors. Eur J Pharmacol 477 (2003) 227-234
123. Mountjoy K.G., Robbins L.S., Mortrud M.T., and Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science 257 (1992) 1248-1251
124. Mountjoy K.G., Mrtrud M.T., Low M.J., Simerly R.B., and Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8 10 (1994) 1298-1308
125. Mugridge K.G., Perretti M., Ghiara P., and Parente L. Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 197 (1991) 151-155
126. Murphy M.T., Richards D.B., and Lipton J.M. Antipyretic potency of centrally administered alpha-melanocyte stimulating hormone. Science 221 (1983) 192-193
127. Neumann Andersen G., Nagaeva O., Mandrika I., Petrovska R., Muceniece R., Mincheva-Nilsson L., et al. MC(1) receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions. Clin Exp Immunol 126 (2001) 441-446
128. Oktar B.K., Ercan F., Yegen B.C., and Alican I. The effect of alpha-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 21 (2000) 1271-1277
129. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22 (2001) 153-183
130. Penhoat A., Jaillard C., and Saez J.M. Corticotropin positively regulates its own receptors and cAMP response in cultured bovine adrenal cells. Proc Natl Acad Sci USA 86 (1989) 4978-4981
131. Raap U., Brzoska T., Sohl S., Path G., Emmel J., Herz U., et al. Alpha-melanocyte-stimulating hormone inhibits allergic airway inflammation. J Immunol 171 (2003) 353-359
132. Rajora N., Boccoli G., Catania A., and Lipton J.M. alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18 (1997) 381-385
133. Rheins L.A., Cotleur A.L., Kleier R.S., Hoppenjans W.B., Saunder D.N., and Nordlund J.J. Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J Invest Dermatol 93 (1989) 511-517
134. Richards D.B., and Lipton J.M. Effect of alpha-MSH 11-13 (lysine-proline-valine) on fever in the rabbit. Peptides 5 (1984) 815-817
135. Ritter J., Kerr L.D., Valeriano-Marcet J., and Spiera H. ACTH Revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems. J Rheumat 21 4 (1994) 696-699
136. Robbins L.S., Nadeau J.H., Johnson K.R., Kelly M.A., Roselli-Rehfuss L., Baack E., et al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72 (1993) 827-834
137. Robertson B., Dostal K., and Daynes R.A. Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J Immunol 140 (1988) 4300-4307
138. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalalmus and limbic system. Proc Natl Acad Sci USA 90 (1993) 8856-8860
139. San T., Oktar B.K., Salik E., Ercan F., and Alican I. The effect of alpha-melanocyte stimulating hormone on endotoxin-induced intestinal injury. Peptides 22 (2001) 2077-2082
140. Sawyer T.K., Sanfilippo P.J., Hruby V.J., Engel M.H., Heward C.B., Burnett J.B., et al. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA 77 (1980) 5754-5758
141. Schioth H.B., Mutulis F., Muceniece R., and Prusis P. Discovery of novel melanocortin4 receptor selective MSH analogues. Br J Pharmacol 124 (1998) 75-82
142. Schioth H.B., Lagerstrom M.C., Watanobe H., Jonsson L., Vergoni A.V., Ringholm A., et al. Functional role, structure, and evolution of the melanocortin-4 receptor. Ann N Y Acad Sci 994 (2003) 74-83
143. Scott A.P., and Lowry P.J. Adrenocorticotropic and melanocyte-stimulating peptides in the human pituitary. Biochem J 139 (1974) 593-602
144. Sebhat I.K., Martin W.J., Ye Z., Barakat K., Mosley R.T., Johnston D.B., et al. Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)-2-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J Med Chem 45 (2002) 4589-4593
145. Shih S.T., Khorram O., Lipton J.M., and McCann S.M. Central administration of alpha-MSH antiserum augments fever in the rabbit. Am J Physiol 250 (1986) R803-R806
146. Smalley K., and Eisen T. The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells. FEBS Lett 476 (2000) 198-202
147. Smolnik R., Perras B., Molle M., Fehm H.L., and Born J. Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone. J Clin Psychopharmacol 20 (2000) 445-454
148. Star R.A., Rajora N., Huang J., Stock R.C., Catania A., and Lipton J.M. Evidence of autocrine modulation of macrophage nitric oxide synthase by a-melanocyte-stimulating hormone. Proc Natl Acad Sci USA 92 (1995) 8016-8020
149. Starowicz K., and Przewlocka B. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci 73 (2003) 823-847
150. Szardenings M., Muceniece R., Mutule I., Mutulis F., and Wikberg J.E. New highly specific agonistic peptides for human melanocortin MC(1) receptor. Peptides 21 (2000) 239-243
151. Taherzadeh S., Sharma S., Chhajlani V., Gantz I., Rajora N., Demitri M.T., et al. α-MSH and its receptors in regulation of tumour necrosis factor-a production by human monocyte/macrophages. Am J Physiol 276 (1999) R1289-R1294
152. Takahashi H., Teranishi Y., Nakanishi S., and Numa S. Isolation and structural organization of the human corticotropin-beta-lipotropin precursor gene. FEBS Lett 135 (1981) 97-102
153. Taylor A., and Namba K. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol Cell Biol 79 (2001) 358-367
154. Uhler M., and Herbert E. Complete amino acid sequence of mouse pro-opiomelanocortin derived from the nucleotide sequence of pro-opiomelanocortin cDNA. J Biol Chem 258 (1983) 257-261
155. Van der Ploeg L.H., Martin W.J., Howard A.D., Nargund R.P., Austin C.P., Guan X., et al. A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci USA 99 (2002) 11381-11386
156. Van der Zee C.E., Brakkee J.H., and Gispen W.H. Alpha-MSH and Org.2766 in peripheral nerve regeneration: different routes of delivery. Eur J Pharmacol 147 (1988) 351-357
157. von Eggelkraut-Gottanka R., and Beck-Sickinger A.G. Biosynthesis of peptide hormones derived from precursor sequences. Curr Med Chem 11 (2004) 2651-2665
158. Vrinten D.H., Kalkman C.J., Adan R.A., and Gispen W.H. Neuropathic pain: a possible role for the melanocortin system?. Eur J Pharmacol 429 (2001) 61-69
159. Wessells H., Levine N., Hadley M.E., Dorr R., and Hruby V. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. Int J Impot Res 12 Suppl 4 (2000) S74-S79
160. Wikberg J.E., Muceniece R., Mandrika I., Prusis P., Lindblom J., Post C., et al. New aspects on the melanocortins and their receptors. Pharmacol Res 42 (2000) 393-420
161. Xia Y., Wikberg J.E., and Chhajlani V. Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport 6 (1995) 2193-2196
162. Xia Y., Wikberg J.E., and Krukoff T.L. Gamma(2)-melanocyte-stimulating hormone suppression of systemic inflammatory responses to endotoxin is associated with modulation of central autonomic and neuroendocrine activities. J Neuroimmunol 120 (2001) 67-77